Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS)
Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS)
批准号:
9906150
负责人:
Kathryn M. Anastos
金额:
$423.52万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
未结题
起止时间:
2019-04-01 至 2026-03-31
关键词:
Acquired Immunodeficiency SyndromeAgeAgingAreaBaltimoreBone DiseasesCaliberCardiovascular DiseasesCardiovascular systemCaringCervicalCervical Cancer ScreeningChronicCohort StudiesCollaborationsCollectionCommunitiesDataData AnalysesData Coordinating CenterDevelopmentDiseaseDisease ProgressionDrug KineticsEchocardiographyEnrollmentEnsureEpidemicEventFarGoFemaleFosteringFractureFundingGeneticGuidelinesHIVHIV InfectionsHIV therapyHealthHuman PapillomavirusHuman papilloma virus infectionImmunologic FactorsInflammationInvestigationInvestigator-Initiated ResearchLeadLeadershipLinkLongevityLongterm Follow-upMalignant NeoplasmsMeasuresMentorshipMetabolicMetabolic DiseasesMetabolismMethodsMethylationMonitorMorbidity - disease rateMucosal ImmunityNatural HistoryNeurocognitive DeficitObesityOutcomeParticipantPathogenesisPatientsPersonsPlayPopulationPrincipal InvestigatorProcessProductivityProtocols documentationPublicationsRaceReadingRecording of previous eventsResearchResearch InfrastructureResearch PersonnelResourcesRiskRoleScienceSeriesSiteSleep disturbancesSpecimenSystemTechniquesThe Multicenter AIDS Cohort StudyUnited StatesUnited States National Institutes of HealthVisceralVisitWomanWomen’s Interagency HIV StudyWorkadjudicationantiretroviral therapycardiovascular imagingcareer developmentcervicovaginal microbiomeclinical research sitecohortcomorbiditydata sharingethnic disparityethnic minority populationexperiencefallsfecal microbiomeflexibilityfrailtyfunctional disabilityhealth disparityimaging studyimmune activationinflammatory markerinnovationmenmetabolomicsmicrobiomemicrobiome componentsmicrobiome researchmortalityoral microbiomeorganizational structureracial minorityrecruitreproductive tractresearch studyretention ratesex disparitysuccesstranslational studytreatment responsevaginal microbiomevaginal mucosa
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Principal Investigator: Anastos, Kathryn/Sharma Anjali
PROJECT SUMMARY/ABSTRACT
With increasingly effective universal antiretroviral therapy (ART), people living with HIV (PLWH) may now
live nearly normal lifespans. With that success however, comes a series of chronic HIV-related comorbidities,
whose mechanisms are poorly understood, but thought to be related to inflammation and immune activation.
As PLWH age, they are experiencing this high burden of non-AIDS comorbidities at younger than expected age,
including cardiovascular and metabolic diseases, cancers, and neurocognitive and functional impairment -
leading some to suggest that HIV may both accentuate AND accelerate aging. The Women's Interagency HIV
Study (WIHS) and the Multicenter AIDS Cohort Study (MACS) cohorts, with long-term follow up over 25 and
35 years provide the ability to measure the onset, progression and impact of HIV-related comorbid disease and
provide a platform for critically important translational studies of pathogenesis in cardiovascular disease
(CVD), human papillomavirus (HPV), aging, and HIV-disease progression. As these two highly successful and
critically important cohorts merge, the Bronx Clinical Research Site (CRS) will support the new Combined
Cohort Study (CCS) in an effort to understand and advance the study of HIV infection and its treatment, with a
focus on HIV-related comorbidities and aging with HIV. The Bronx CRS will provide scientific leadership to
the CCS in three specific areas: CVD, microbiome studies, and HPV infection and disease. In particular, the
Bronx CRS will provide innovative scientific leadership in studying CVD among PLWH with a longitudinal
echocardiography study and a high-caliber Echo Reading Center, including cutting-edge cardiovascular
imaging, and the study of CVD in relation to inflammatory markers, metabolomics, and microbiome among
PLWH. The Bronx CRS will continue to follow our large numbers of well-characterized persons living with and
without HIV, as well as recruit primarily racial and ethnic minority men and women with or at-risk for HIV to
reflect our local NYC HIV epidemic, thus allowing us to investigate the impact of age, sex, race/ethnicity, and
health disparities on HIV disease progression and its relation to comorbid illnesses across the lifespan. The
value of these studies goes far beyond the United States, to inform the global HIV epidemic, and care of PLWH.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Rwanda CASCADE Clinical Trials Site for cervical cancer prevention
-
批准号:10757692
-
项目类别:
-
资助金额:$22.63万
-
财政年份:2023
-
负责人:Kathryn M. Anastos
-
依托单位:
Einstein/Rwanda DRC Consortium for Research in HIV/HPV Malignancies
-
批准号:10414093
-
项目类别:
-
资助金额:$24.62万
-
财政年份:2020
-
负责人:Kathryn M. Anastos
-
依托单位:
Einstein/Rwanda/DRC Consortium for Research in HIV/HPV/ Malignancies
-
批准号:10267220
-
项目类别:
-
资助金额:$8.34万
-
财政年份:2020
-
负责人:Kathryn M. Anastos
-
依托单位:
Einstein/Rwanda/DRC Consortium for Research in HIV/HPV Malignancies
-
批准号:10267222
-
项目类别:
-
资助金额:$36.25万
-
财政年份:2020
-
负责人:Kathryn M. Anastos
-
依托单位:
Einstein/Rwanda DRC Consortium for Research in HIV/HPV Malignancies
-
批准号:10267223
-
项目类别:
-
资助金额:$20.44万
-
财政年份:2020
-
负责人:Kathryn M. Anastos
-
依托单位:
Einstein/Rwanda/DRC Consortium for Research in HIV/HPV/ Malignancies
-
批准号:10654706
-
项目类别:
-
资助金额:$6.84万
-
财政年份:2020
-
负责人:Kathryn M. Anastos
-
依托单位:
Einstein/Rwanda/DRC Consortium for Research in HIV/HPV Malignancies
-
批准号:10654712
-
项目类别:
-
资助金额:$47.63万
-
财政年份:2020
-
负责人:Kathryn M. Anastos
-
依托单位:
Einstein/Rwanda/DRC Consortium for Research in HIV/HPV Malignancies
-
批准号:10084653
-
项目类别:
-
资助金额:$9.68万
-
财政年份:2020
-
负责人:Kathryn M. Anastos
-
依托单位:
Einstein/Rwanda DRC Consortium for Research in HIV/HPV Malignancies
-
批准号:10084655
-
项目类别:
-
资助金额:$25.88万
-
财政年份:2020
-
负责人:Kathryn M. Anastos
-
依托单位:
Einstein/Rwanda/DRC Consortium for Research in HIV/HPV/Malignancies
-
批准号:10654699
-
项目类别:
-
资助金额:$22.52万
-
财政年份:2020
-
负责人:Kathryn M. Anastos
-
依托单位:
Einstein/Rwanda/DRC Consortium for Research in HIV/HPV/Malignancies
-
批准号:10267219
-
项目类别:
-
资助金额:$22.05万
-
财政年份:2020
-
负责人:Kathryn M. Anastos
-
依托单位:
Einstein/Rwanda/DRC Consortium for Research in HIV/HPV/Malignancies
-
批准号:10084651
-
项目类别:
-
资助金额:$20.85万
-
财政年份:2020
-
负责人:Kathryn M. Anastos
-
依托单位:
Einstein/Rwanda/DRC Consortium for Research in HIV/HPV Malignancies
-
批准号:10084654
-
项目类别:
-
资助金额:$33.37万
-
财政年份:2020
-
负责人:Kathryn M. Anastos
-
依托单位:
Einstein/Rwanda/DRC Consortium for Research in HIV/HPV Malignancies
-
批准号:10414091
-
项目类别:
-
资助金额:$9.81万
-
财政年份:2020
-
负责人:Kathryn M. Anastos
-
依托单位:
Einstein/Rwanda/DRC Consortium for Research in HIV/HPV/Malignancies
-
批准号:10414089
-
项目类别:
-
资助金额:$20.4万
-
财政年份:2020
-
负责人:Kathryn M. Anastos
-
依托单位:
Einstein/Rwanda/DRC Consortium for Research in HIV/HPV/ Malignancies
-
批准号:10414090
-
项目类别:
-
资助金额:$8.09万
-
财政年份:2020
-
负责人:Kathryn M. Anastos
-
依托单位:
Einstein/Rwanda/DRC Consortium for Research in HIV/HPV Malignancies
-
批准号:10414092
-
项目类别:
-
资助金额:$33.4万
-
财政年份:2020
-
负责人:Kathryn M. Anastos
-
依托单位:
Einstein/Rwanda/DRC Consortium for Research in HIV/HPV/ Malignancies
-
批准号:10084652
-
项目类别:
-
资助金额:$9.05万
-
财政年份:2020
-
负责人:Kathryn M. Anastos
-
依托单位:
Einstein/Rwanda/DRC Consortium for Research in HIV/HPV Malignancies
-
批准号:10267221
-
项目类别:
-
资助金额:$9.52万
-
财政年份:2020
-
负责人:Kathryn M. Anastos
-
依托单位:
MACS/WIHS Combined Cohort Study (MWCCS) Administrative Supplement: Association of Oral Microbiome, HIV, and Pulmonary Function
-
批准号:10654917
-
项目类别:
-
资助金额:$1.01万
-
财政年份:2019
-
负责人:Kathryn M. Anastos
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: